Siemens Healthcare Diagnostics, Inc. has recalled approximately 147,103 DCA Systems HbA1c Reagent Kits used for measuring blood glucose control in diabetic patients. The recall was initiated because eleven lots of these test kits were confirmed to display a positive bias, meaning they may report falsely high blood sugar levels without alerting the user. If you use this device for glucose management, contact your healthcare provider or the manufacturer for instructions on how to handle affected materials.
The defect causes the device to report test results that are up to 19% higher than actual levels, which could lead to incorrect patient management of glucose control. This poses a risk of improper medication dosing or treatment decisions based on erroneous diagnostic data.
Medical Device Guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.